Regenerative Medicine Foundation "Stem Cell Action Award"

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Regenerative Medicine Foundation "Stem Cell Action Award" Honorees Announced for 2016

WEST PALM BEACH, FL --(Marketwired - November 02, 2016) - Four distinguished honorees have been selected for the 2016 Stem Cell Action Awards . For 12 years, the nonprofit organization, now known as Regenerative Medicine Foundation , has honored the stem cell and regenerative medicine community's top innovators, leaders, and champions. The honorees are recognized at a gala reception and dinner on Wednesday, December 7 during the 12 th annual World Stem Cell Summit & RegMed Capital Conference at the Palm Beach County Convention Center in West Palm Beach, Florida.

This year's Stem Cell Action Award Honorees include a path-finding diabetes researcher motivating the biomedical community to take a stand for cures, two visionary philanthropists strategically building translational research projects and a devoted mother, turned advocate, who is creating awareness about the scourge of childhood cancer. All four have devoted themselves to accelerating stem cell and regenerative medicine to improve health and deliver cures.

Meet the 2016 Stem Cell Action Award Honorees: Leadership Award: Bernie Marcus - Stem cell and regenerative medicine benefactor, Bernie Marcus, is a recipient of a "Leadership" award for his visionary strategic philanthropy. The co-founder and former CEO of The Home Depot, has provided grants through the Marcus Foundation, to fund the new Georgia Tech Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M), as well as clinical stem cell trials and research in the treatment of autism, stroke and cerebral palsy at Duke, asthma and lung disease at the University of Miami and Case Western Reserve, neonatal heart disease at Emory and Children's Hospital of Atlanta, and cancer cellular therapy trials at City of Hope, Penn, Miami and MD Anderson. The Marcus Foundation has also created centers of excellence in Autism, Stroke, Trauma, Emergency Medicine, Integrative Health, Neuroscience, and Heart disease in Atlanta, Philadelphia, and Boca Raton.

Leadership Award: Don Soffer - The celebrated Florida real estate developer Don Soffer, who created the thriving Aventura community, will be honored with a "Leadership" award. Under his stewardship, the Soffer family provided a transformative $25 million gift to the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine. The contribution has boosted ISCI into the highest orbit of translational regenerative medicine.

Advocacy Award: Camillo Ricordi, M.D. - Dr. Ricordi is the director of the Diabetes Research Institute and Cell Transplant Program at the University of Miami Miller School of Medicine. Acknowledged as one of the world's leading scientists in diabetes cure-focused research and cell transplantation, Dr. Ricordi has author over 1,000 scientific publications. He has been awarded 25 patents including the automated method and Ricordi Chamber used to obtain large numbers of insulin producing cells from the human pancreas. The technology was used in the first successful islet cell transplants and is still used worldwide for clinical islet transplantation. He is currently working on immunomodulation and stem cell strategies to reverse autoimmunity, and on biologic replacement platform technologies "BioHUB" for the cure of diabetes without the need for anti-rejection drugs. Dr. Ricordi has also devoted himself to supporting the cause of stem cell research. He is a founding member of the science advisory board of Genetics Policy Institute and in 2004 he spoke at the organization's seminal meeting at the United Nations headquarters. He founded and served as the first president of The Cure Alliance, an important advocacy nonprofit organization whose primary goal is to promote collaborative efforts and help accelerate potential cures from the laboratory to the bedside.

Inspiration Award: Sandy Barker and The Gold Rush Cure Foundation - Sandy Barker and her husband Gary founded Gold Rush Cure Foundation in memory of their beloved son, Christian Gordon Barker. Besides supporting children battling cancer via their "Pot of Gold" program, the foundation commits itself to advocating both locally and nationally for increased awareness and research funding for childhood cancer. Sandy will be making her 20th advocacy trip in February 2017. She has distinguished herself as a key spokesperson and advocate supporting an accelerated regulatory pathway for regenerative cellular therapies. Sandy sees the vital need for improvement in this area as she mentors numerous families affected by childhood cancer.

Some of the previous Stem Cell Action awardees have included Michael J. Fox, Brooke Ellison, Robert Klein, Bob Nerem, Susan Solomon, Ann Murphy, Mary Ann Liebert, Research!America, National Association of Biology Teachers, Juvenile Diabetes Research Foundation (JDRF), the Huntington's Disease "grassroots" advocacy community, ALS Worldwide, and philanthropists like A. Alfred Taubman and T. Denny Sanford.

ABOUT WORLD STEM CELL SUMMIT:

The World Stem Cell Summit & RegMed Capital Conference is the original translational regenerative medicine conference. The Summit aims to accelerate the discovery and development of lifesaving cures and therapies, bringing global stakeholders together to solve global challenges. The 2016 Summit Organizing Partners are: Regenerative Medicine Foundation (RMF), Center for Advancement of Science in Space (CASIS), Mayo Clinic, Kyoto University Institute for Integrated Cell-Material Sciences (iCeMS), Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine, Wake Forest Institute for Regenerative Medicine, Diabetes Research Institute Foundation, The Cure Alliance, Centre for Commercialization for Regenerative Medicine (CCRM) and Nova Southeastern University Cell Therapy Institute, More than 225 speakers and panelists will discuss the latest scientific discoveries, funding opportunities, translational issues, legal and regulatory solutions, and best practices. The event is expected to attract more than 1,200 attendees from 35 nations. The Summit will be held December 6-9, 2016, at the Palm Beach County Convention Center, West Palm Beach, Florida.

ABOUT REGENERATIVE MEDICINE FOUNDATION (RMF):

Regenerative Medicine Foundation (formerly called Genetics Policy Institute) is a 501(c)(3) nonprofit organization dedicated to accelerating regenerative medicine to improve health and deliver cures. We pursue our mission by producing the World Stem Cell Summit & RegMed Capital Conference, honoring community leaders through the Stem Cell Action Awards, supporting our official journal partner STEM CELLS Translational Medicine published by AlphaMed Press, organizing educational and policy initiatives and fostering strategic collaborations. RMF maintains offices in Florida and California. For more information about RMF, visit www.regmedfoundation.org .

Visit worldstemcellsummit.com and follow @WSCSummit on Twitter. For information about sponsoring or attending the World Stem Cell Summit and the Stem Cell Action Awards, contact Alan Fernandez at (650) 847-1640 or email alan@regmedfoundation.org.

Image Available: http://www.marketwire.com/library/MwGo/2016/1...c7c0c6.jpg

Alan Fernandez Associate Director Regenerative Medicine Foundation alan@regmedfoundation.org 1-650-759-8300

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading